Text Size

One-year results on the safety and efficacy of the InnFocus MicroShunt depending on placement and concentration of mitomycin C [Résultats à un an de l’efficacité et de l’innocuité du MicroShunt InnFocus selon l’emplacement et la concentration de MMC]

Riss I., Batlle J., Pinchuk L., Kato Y.P., Weber B.A., Parel J.-M.


  • 2015
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Pôle Ophtalmologique, Clinique Mutualiste, 46/54, avenue du Dr-Albert-Schweitzer, Pessac, 33600, France; Centro Laser, Santo Domingo, Calle Padre Fantino Falco 3, Santo Domingo, Dominica; InnFocus Inc., 12415 SW 136th Avenue #3, Miami, FL 33186, United States; Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller, 900 NW 17th Street, Miami, FL 33136, United States

Related Publications

Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats

Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.


A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.


Valproic Acid Application to Modify Post Surgical Fibrosis in a Model of Minimally Invasive Bleb Surgery

Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022